ox-LDL regulates proliferation and apoptosis in VSMCs by controlling the miR-183-5p/FOXO1

다국어 초록 (Multilingual Abstract)

Background: microRNA-mRNA axes that are involved in oxidized low-density lipoprotein (ox-LDL)-induced vascular smooth muscle cells (VSMCs) proliferation/apoptosis imbalance need to be further investigated.
Objective: To investigate the functional role of miR-183-5p/FOXO1 in VSMCs and its interaction with ox-LDL.
Methods: RNA sequencing was used to detect transcriptome changes of VSMCs treated with ox-LDL. miR-183-5p and FOXO1 expression levels in VSMCs after ox-LDL treatment were assessed using qRT-PCR and western blotting. The regulatory effect of miR-183-5p on FOXO1 has been tried to prove using a dual-luciferase reporter assay. The functions of miR-183-5p, and FOXO1 were analyzed by CCK-8 assay and flow cytometry assay. The tissue samples or serum samples of high fat-feeding mice and carotid atherosclerosis patients were collected, and the levels of miR-183-5p/FOXO1 were analyzed.
Results: RNA sequencing data showed 81 miRNAs including miR-183-5p was significantly changed after ox-LDL treatment in VSMCs. FOXO1, a miR-183-5p's potential target, was also down-regulated in ox-LDL treated cells. qRT-PCR and western blot found that expression of FOXO1 mRNA and protein significantly reduced in VSMCs treated with ox-LDL, accompanied by overexpression of miR-183-5p. miR-183-5p inhibited FOXO1 mRNA by binding to its 3' UTR. Interference miR-183-5p/FOXO1 could change proliferation/apoptosis imbalance in VSMCs under ox-LDL stimulation. Higher levels of miR-183-5p but reduced FOXO1 can be found in the thoracic aorta tissues of high fat-feeding mice. In serum samples from individuals with carotid atherosclerosis, Higher levels of miR-183-5p were observed. the miR-183-5p level was positively related to the level of serum ox-LDL in patients.
Conclusions: Aberrant expression of miR-183-5p/FOXO1 pathway mediated ox-LDL-induced proliferation/apoptosis imbalance in VSMCs. The miR-183-5p/FOXO1 axis can potentially be utilized as the target in the treatment of patients with atherosclerosis.

참고문헌 (Reference)

1 Ouimet M, "microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis" 37 : 1058-1067, 2017

2 Yang L, "miR-96 enhances the proliferation of cervical cancer cells by targeting FOXO1" 216 : 152854-, 2020

3 Farina FM, "miR-128-3p Is a Novel Regulator of Vascular Smooth Muscle Cell Phenotypic Switch and Vascular Diseases" 127 : e141-, 2020

4 Wang X, "Suppression of miR-4463 promotes phenotypic switching in VSMCs treated with Ox-LDL" 383 : 1155-1165, 2021

5 Zhang MJ, "SIRT1 improves VSMC functions in atherosclerosis" 121 : 11-15, 2016

6 Rocha KK, "Resveratrol toxicity : effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets" 47 : 1362-1367, 2009

7 Shen J, "Proliferation of Vascular Smooth Muscle Cells under ox-LDL Is Regulated by Alismatis rhizoma Decoction via InhibitingERK1/2 and miR-17 approximately 92a Cluster Activation" 2020 : 7275246-, 2020

8 Wang YS, "MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation" 95 : 517-526, 2012

9 Schober A, "MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1" 20 : 368-376, 2014

10 Zhang C, "MicroRNA and vascular smooth muscle cell phenotype : new therapy for atherosclerosis?" 1 : 85-, 2009

11 Feinberg MW, "MicroRNA Regulation of Atherosclerosis" 118 : 703-720, 2016

12 Sun Y, "MiR-490-3p modulates the proliferation of vascular smooth muscle cells induced by ox-LDL through targeting PAPP-A" 100 : 272-279, 2013

13 Wang H, "MiR-377-3p inhibits atherosclerosis-associated vascular smooth muscle cell proliferation and migration via targeting neuropilin2" 40 : 2020

14 Jin C, "MiR-182-5p Inhibits the Proliferation of Vascular Smooth Muscle Cells Induced by ox-LDL Through Targeting PAPPA" 61 : 822-830, 2020

15 Lu X, "MiR-135a Promotes Inflammatory Responses of Vascular Smooth Muscle Cells From db/db Mice via Downregulation of FOXO1" 59 : 170-179, 2018

16 Chen T, "Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis" 53 : 102706-, 2020

17 Wang A, "MEG3 promotes proliferation and inhibits apoptosis in osteoarthritis chondrocytes by miR-361-5p/FOXO1 axis" 12 : 201-, 2019

18 Gao H, "LncRNA XIST regulates atherosclerosis progression in ox-LDL-induced HUVECs" 16 : 117-127, 2021

19 Wu X, "LncRNA TUG1 regulates proliferation and apoptosis by regulating miR-148b/IGF2 axis in ox-LDL-stimulated VSMC and HUVEC" 243 : 117287-, 2020

20 Tao J, "Interaction Between microRNA and DNA Methylation in Atherosclerosis" 40 : 101-115, 2021

21 Deng L, "Inhibition of FOXO1/3 promotes vascular calcification" 35 : 175-183, 2015

22 Jia C, "Identification and functional analysis of changes to the ox-LDL-induced microRNA-124-3p/DLX5 axis in vascular smooth muscle cells" 2021

23 Abid MR, "Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia" 280 : 29864-29873, 2005

24 Gao H, "Exosomal MALAT1 derived from ox-LDL-treated endothelial cells induce neutrophil extracellular traps to aggravate atherosclerosis" 401 : 367-376, 2020

25 Ding P, "Circular RNA circ_0010283 regulates the viability and migration of oxidized lowdensity lipoproteininduced vascular smooth muscle cells via an miR3703p/HMGB1 axis in atherosclerosis" 46 : 1399-1408, 2020

26 Chen Z, "Baicalin Suppresses the Proliferation and Migration of Ox-LDL-VSMCs in Atherosclerosis through Upregulating miR-126-5p" 42 : 1517-1523, 2019

27 Chepelenko GV, "Atherosclerosis regulation via media lipiddriven VSMC cholesterol efflux switch" 84 : 141-144, 2015